13.84
0.36%
0.05
Dopo l'orario di chiusura:
13.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WVE Giù?
Forum
Previsione
Precedente Chiudi:
$13.79
Aprire:
$13.84
Volume 24 ore:
999.94K
Relative Volume:
0.62
Capitalizzazione di mercato:
$2.10B
Reddito:
$113.31M
Utile/perdita netta:
$-57.51M
Rapporto P/E:
-10.18
EPS:
-1.36
Flusso di cassa netto:
$-20.55M
1 W Prestazione:
-6.49%
1M Prestazione:
+64.57%
6M Prestazione:
+125.41%
1 anno Prestazione:
+145.39%
Wave Life Sciences Ltd Stock (WVE) Company Profile
Nome
Wave Life Sciences Ltd
Settore
Industria
Telefono
617-949-2900
Indirizzo
7 STRAITS VIEW, SINGAPORE
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-09-27 | Ripresa | JP Morgan | Overweight |
2024-09-19 | Iniziato | B. Riley Securities | Buy |
2024-09-09 | Iniziato | JP Morgan | Overweight |
2024-05-15 | Iniziato | Wells Fargo | Overweight |
2023-12-19 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
2023-07-05 | Iniziato | Raymond James | Outperform |
2023-05-24 | Downgrade | Jefferies | Buy → Hold |
2020-12-15 | Ripresa | H.C. Wainwright | Buy |
2020-10-23 | Iniziato | RBC Capital Mkts | Sector Perform |
2019-12-31 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2019-11-01 | Iniziato | Guggenheim | Buy |
2019-07-15 | Iniziato | Cowen | Market Perform |
2019-04-17 | Reiterato | H.C. Wainwright | Buy |
2018-08-07 | Iniziato | Stifel | Buy |
2018-07-23 | Iniziato | H.C. Wainwright | Buy |
2018-03-19 | Reiterato | Mizuho | Buy |
2017-02-15 | Iniziato | H.C. Wainwright | Buy |
2016-11-10 | Ripresa | Leerink Partners | Outperform |
2015-12-07 | Iniziato | JMP Securities | Mkt Outperform |
2015-12-07 | Iniziato | Jefferies | Buy |
2015-12-07 | Iniziato | Leerink Partners | Outperform |
2015-12-07 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
Mostra tutto
Wave Life Sciences Ltd Borsa (WVE) Ultime notizie
Wave Life Sciences (WVE) to Release Earnings on Tuesday - MarketBeat
Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024 - StockTitan
B. Riley Increases Wave Life Sciences (NASDAQ:WVE) Price Target to $22.00 - MarketBeat
Institutional investors in Wave Life Sciences Ltd. (NASDAQ:WVE) see US$94m decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance
Emerald Advisers LLC Purchases 388,280 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
Wave Life Sciences' (WVE) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
Those who invested in Wave Life Sciences (NASDAQ:WVE) three years ago are up 195% - Simply Wall St
Wave Life Sciences Highlights Growing Pipeline at Research - GlobeNewswire
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs - StockTitan
How to play biotech stocks: Insmed and Wave Life Sciences - Yahoo Finance
Analysts Set Wave Life Sciences Ltd. (NASDAQ:WVE) Target Price at $19.44 - MarketBeat
Wall Street Analysts Predict a 34.53% Upside in Wave Life Sciences (WVE): Here's What You Should Know - Yahoo Finance
(WVE) Technical Data - Stock Traders Daily
Wave Life Sciences stock slides 31% after company prices $100 million secondary share offering - MSN
Can Wave Life Sciences Make Waves With Forward-53 DMD Trial Data? - RTTNews
Asia Deal Watch: Cureverse Licenses Option For Neurology Candidate To Angelini - Scrip
WAVE Life Sciences (STU:1U5) Growth Rank : 2 (As of Oct. 25, 2024) - GuruFocus.com
WaVe Life Sciences' SWOT analysis: RNA editing pioneer's stock faces pivotal trials - Investing.com India
Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Moody Aldrich Partners LLC - MarketBeat
1 Brand-New Big Reason to Buy This Biotech Stock Right Now - Yahoo Finance
VRTX: 3 Pharma Stocks to Watch as Gene Therapy Gains Momentum - StockNews.com
What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now? - Yahoo Finance
RBC Capital raises WAVE Life Sciences stock target By Investing.com - Investing.com Australia
Venture funds, a new chapter for MS & Wave’s data: a BioCentury podcast - BioCentury
Wave Life Sciences (NASDAQ:WVE) PT Raised to $15.00 at Royal Bank of Canada - MarketBeat
Wave Life Sciences Rockets 70% on Historic RNA Editing Success - MSN
Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio? - Benzinga
SG Americas Securities LLC Has $300,000 Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat
WVE Stock Soars on Upbeat Initial Antitrypsin Deficiency Study Data - MSN
Insider Sale: President and CEO Paul Bolno Sells 90,474 Shares o - GuruFocus.com
Wave Life Sciences' Chris Francis sells $2.86 million in shares By Investing.com - Investing.com Australia
Wave Life Sciences Ltd. (NASDAQ:WVE) CEO Paul Bolno Sells 90,474 Shares - MarketBeat
Wave Life Sciences CEO Paul Bolno sells $1.36 million in shares By Investing.com - Investing.com South Africa
Wave Life Sciences CEO Paul Bolno sells $1.36 million in shares - Investing.com
Wave Life Sciences' Chris Francis sells $2.86 million in shares - Investing.com
Leerink Partnrs Analysts Raise Earnings Estimates for WVE - MarketBeat
Wave Life Sciences Rockets 70% On Historic RNA Editing Success - Barchart
WVE (WAVE Life Sciences) Change In Inventory : $0.0 Mil (TTM As of Jun. 2024) - GuruFocus.com
WVE (WAVE Life Sciences) Earnings per Share (Diluted) : $-0.57 (TTM As of Jun. 2024) - GuruFocus.com
Wave Life Sciences (NASDAQ:WVE) Shares Gap DownHere's What Happened - MarketBeat
Wave Life Sciences Shares Surge After RNA Editing Discovery - Yahoo Finance
JPMorgan Chase & Co. Increases Wave Life Sciences (NASDAQ:WVE) Price Target to $17.00 - MarketBeat
Wave claims first clinical RNA editing title in rare genetic disease - BioPharma-Reporter.com
Takeda terminates deal with Wave - The Pharma Letter
Wave Life Sciences (NASDAQ:WVE) Receives Buy Rating from HC Wainwright - MarketBeat
WAVE Life Sciences stock's Buy rating and price target reaffirmed by H.C. Wainwright - Investing.com UK
Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last? - Yahoo Finance
WVE Stock Soars 74% as Wave Life Sciences Achieves RNA Editing Breakthrough - MoneyCheck
Wave surges on first RNA editing data in humans - pharmaphorum
Wave data propel RNA-editing stocks, but are all platforms created equal? - BioCentury
WAVE Life Sciences (FRA:1U5) 50-Day SMA : €5.85 (As of Oct. 16, 2024) - GuruFocus.com
Wave Life Sciences Ltd Azioni (WVE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Wave Life Sciences Ltd Azioni (WVE) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Francis Chris | See Remarks |
Oct 16 '24 |
Sale |
13.67 |
208,836 |
2,855,051 |
0 |
BOLNO PAUL | President and CEO |
Oct 16 '24 |
Sale |
15.00 |
90,474 |
1,357,110 |
268,585 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):